Levetiracetam for Seizure Prevention After Brain Tumor Surgery

Clinical trial NCT07239115 · RECRUITING

Trial details

NCT number: NCT07239115
Sponsor: Beijing Tiantan Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Postoperative Seizures After Brain Tumor Surgery

Start date: 2026-05-14
Primary completion: 2027-01-01
Enrollment: 558

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.